Literature DB >> 11790989

Giant cell arteritis.

Stuart M Levine1, David B Hellmann.   

Abstract

Giant cell arteritis (GCA), the most common form of systemic vasculitis in adults, preferentially involves large and medium-sized arteries in patients over the age of 50. The classic manifestations are headache, jaw claudication, polymyalgia rheumatica (PMR), and visual symptoms, but 40% of patients present with a wide range of occult manifestations. Early diagnosis and treatment with prednisone can prevent blindness, the most feared complication of GCA. The pathogenesis of GCA is T-cell dependent and antigen driven. Clinical subsets of GCA appear to result from variable cytokine expression. The risk of developing thoracic aortic aneurysm is increased more than 17-fold in patients with GCA. GCA can also involve large arteries, especially the subclavian and axillary arteries. Color Doppler ultrasound, magnetic resonance imaging, and positron-emission tomography scanning are providing insights into the extent and pathogenesis of the disease but have not replaced temporal artery biopsy as the gold standard for securing the diagnosis. Two recently completed double-blind, placebo-controlled trials concerning whether methotrexate plus prednisone is more effective than prednisone alone reached conflicting conclusions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11790989     DOI: 10.1097/00002281-200201000-00002

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  11 in total

1.  Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI.

Authors:  J Meller; F Strutz; U Siefker; A Scheel; C O Sahlmann; K Lehmann; M Conrad; R Vosshenrich
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-04       Impact factor: 9.236

2.  Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: a multicenter retrospective study.

Authors:  G A Hooisma; H Balink; P M Houtman; R H J A Slart; K D F Lensen
Journal:  Clin Rheumatol       Date:  2012-02-10       Impact factor: 2.980

Review 3.  Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy; Javier Martin
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  A woman with temporal pain.

Authors:  Lauren Fine; Scott Kurpiel; Ashley Carter
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-06-07

5.  Giant Cell Arteritis.

Authors:  Jennifer K. Hall; Laura J. Balcer
Journal:  Curr Treat Options Neurol       Date:  2004-01       Impact factor: 3.598

6.  Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  M Lopez-Hoyos; M J Bartolome-Pacheco; R Blanco; V Rodriguez-Valverde; V M Martinez-Taboada
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

7.  Balloon angioplasty of arteries of the upper extremities in patients with extracranial giant-cell arteritis.

Authors:  M Both; P M Aries; S Müller-Hülsbeck; T Jahnke; P J Schäfer; W L Gross; M Heller; M Reuter
Journal:  Ann Rheum Dis       Date:  2006-02-07       Impact factor: 19.103

8.  An uneven expression of T cell receptor V genes in the arterial wall and peripheral blood in giant cell arteritis.

Authors:  C Schaufelberger; R Andersson; E Nordborg; G K Hansson; C Nordborg; J Wahlström
Journal:  Inflammation       Date:  2008-12       Impact factor: 4.092

9.  [Large-vessel vasculitis. Imaging and interventional therapy].

Authors:  M Both; F Moosig; W L Gross; M Heller
Journal:  Radiologe       Date:  2009-10       Impact factor: 0.635

10.  Giant Cell Arteritis: An Atypical Presentation Diagnosed with the Use of MRI Imaging.

Authors:  Siddesh Shambhu; Lisbet Suarez
Journal:  Case Rep Rheumatol       Date:  2016-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.